Viemed Healthcare (VMD)
(Real Time Quote from BATS)
$7.30 USD
-0.10 (-1.35%)
Updated Sep 10, 2024 02:10 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Viemed Healthcare, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 183 | 139 | 117 | 131 | 80 |
Cost Of Goods | 70 | 54 | 44 | 51 | 24 |
Gross Profit | 113 | 85 | 73 | 80 | 56 |
Selling & Adminstrative & Depr. & Amort Expenses | 98 | 77 | 63 | 60 | 47 |
Income After Depreciation & Amortization | 15 | 8 | 10 | 21 | 9 |
Non-Operating Income | 0 | 2 | 2 | 6 | 0 |
Interest Expense | 0 | 0 | 0 | 1 | 0 |
Pretax Income | 14 | 9 | 13 | 26 | 9 |
Income Taxes | 4 | 3 | 3 | -5 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 10 | 6 | 9 | 32 | 9 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 10 | 6 | 9 | 32 | 9 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 37 | 23 | 22 | 30 | 16 |
Depreciation & Amortization (Cash Flow) | 22 | 16 | 11 | 10 | 6 |
Income After Depreciation & Amortization | 15 | 8 | 10 | 21 | 9 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 40.38 | 39.81 | 40.68 | 40.53 | 39.75 |
Diluted EPS Before Non-Recurring Items | 0.25 | 0.16 | 0.22 | 0.78 | 0.21 |
Diluted Net EPS (GAAP) | 0.25 | 0.16 | 0.22 | 0.78 | 0.21 |
Fiscal Year end for Viemed Healthcare, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 54.97 | 50.59 | 50.74 | 49.40 | 43.31 |
Cost Of Goods | 22.07 | 20.79 | 18.63 | 18.84 | 17.21 |
Gross Profit | 32.89 | 29.80 | 32.11 | 30.56 | 26.11 |
SG&A, R&D, and Dept/Amort Expenses | 29.26 | 27.42 | 26.52 | 26.12 | 23.09 |
Income After SG&A, R&D, and Dept/Amort Expenses | 3.63 | 2.38 | 5.59 | 4.44 | 3.02 |
Non-Operating Income | -1.14 | -0.12 | -0.26 | 0.03 | 0.02 |
Interest Expense | 0.25 | 0.15 | 0.26 | 0.24 | -0.02 |
Pretax Income | 2.25 | 2.12 | 5.08 | 4.24 | 3.06 |
Income Taxes | 0.77 | 0.52 | 1.60 | 1.32 | 0.73 |
Minority Interest | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 1.48 | 1.60 | 3.48 | 2.92 | 2.33 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 1.47 | 1.60 | 3.48 | 2.92 | 2.33 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 40.55 | 40.58 | 40.38 | 40.42 | 40.68 |
Diluted EPS Before Non-Recurring Items | 0.04 | 0.04 | 0.09 | 0.07 | 0.06 |
Diluted Net EPS (GAAP) | 0.04 | 0.04 | 0.08 | 0.07 | 0.06 |